{"id":"https://openalex.org/W2390412262","doi":null,"title":"Inappropriate Drug Therapy for Hypertrophic Obstructive Cardiomyopathy","display_name":"Inappropriate Drug Therapy for Hypertrophic Obstructive Cardiomyopathy","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W2390412262","mag":"2390412262"},"language":"en","primary_location":{"id":"mag:2390412262","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGXH200705014.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764942192","display_name":"Zhongguo xunhuan zazhi","issn_l":"1000-3614","issn":["1000-3614"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo xunhuan zazhi","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109298798","display_name":"Zhi-min Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Zhi-min Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5109298798"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.40058008,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10882","display_name":"Cardiomyopathy and Myosin Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10882","display_name":"Cardiomyopathy and Myosin Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypertrophic-obstructive-cardiomyopathy","display_name":"hypertrophic obstructive cardiomyopathy","score":1.0},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.6610000133514404},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9359999895095825},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9829999804496765},{"id":"https://openalex.org/keywords/diuretics","display_name":"diuretics","score":0.9739999771118164},{"id":"https://openalex.org/keywords/digoxin","display_name":"digoxin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nitrate","display_name":"nitrate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/amiodarone","display_name":"amiodarone","score":0.847000002861023},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.6949999928474426},{"id":"https://openalex.org/keywords/diltiazem","display_name":"diltiazem","score":0.949999988079071},{"id":"https://openalex.org/keywords/dihydropyridines","display_name":"dihydropyridines","score":0.8410000205039978},{"id":"https://openalex.org/keywords/antihypertensive-therapy","display_name":"antihypertensive therapy","score":0.6079999804496765}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9178572297096252},{"id":"https://openalex.org/C2776741139","wikidata":"https://www.wikidata.org/wiki/Q422229","display_name":"Diltiazem","level":3,"score":0.8556299209594727},{"id":"https://openalex.org/C2777707475","wikidata":"https://www.wikidata.org/wiki/Q422222","display_name":"Digoxin","level":3,"score":0.756572961807251},{"id":"https://openalex.org/C85520022","wikidata":"https://www.wikidata.org/wiki/Q15322916","display_name":"Calcium channel","level":3,"score":0.6704221963882446},{"id":"https://openalex.org/C2777022698","wikidata":"https://www.wikidata.org/wiki/Q410291","display_name":"Verapamil","level":3,"score":0.6679605841636658},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5291640758514404},{"id":"https://openalex.org/C2778094803","wikidata":"https://www.wikidata.org/wiki/Q410061","display_name":"Amiodarone","level":3,"score":0.5282670259475708},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.46343404054641724},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41988953948020935},{"id":"https://openalex.org/C2780356492","wikidata":"https://www.wikidata.org/wiki/Q421700","display_name":"Calcium channel blocker","level":3,"score":0.4198282063007355},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.40335315465927124},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.3831482529640198},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.3261450529098511},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.18036720156669617},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2390412262","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGXH200705014.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764942192","display_name":"Zhongguo xunhuan zazhi","issn_l":"1000-3614","issn":["1000-3614"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo xunhuan zazhi","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387006852","https://openalex.org/W4416252427","https://openalex.org/W4303858587","https://openalex.org/W2362705901","https://openalex.org/W4391513039","https://openalex.org/W2416610790","https://openalex.org/W2421990634","https://openalex.org/W17768659","https://openalex.org/W2400626952","https://openalex.org/W2427773109"],"abstract_inverted_index":{"Objective:To":[0],"investigate":[1],"the":[2],"medical":[3],"treatment":[4],"of":[5,13,28,120],"hypertrophic":[6],"obstructive":[7],"cardiomyopathy(HOCM).Methods:Three":[8],"hundred":[9,87,106],"and":[10,40,88,107,126],"three":[11],"patients":[12,74],"HOCM":[14,121],"in":[15],"Fu":[16],"Wai":[17],"hospital":[18],"from":[19],"January":[20],"1992":[21],"to":[22],"December":[23],"2006":[24],"were":[25,38,42,47,54,80,90,94,97,100,103,109,122],"studied.The":[26],"prescriptions":[27],"adrenergic":[29,45,56,67,124],"beta-antagonists,calcium":[30],"channel":[31,51,61,71,78,128],"blockers,angiotensin-converting":[32],"enzyme":[33],"inhibitors(ACE":[34],"inhibitors)/angiotensin":[35],"\u2161receptor":[36],"blockers(ARB),diuretics,digoxin,nitrates":[37],"collected":[39],"evaluated.Results:\u2460Ninety-one(30.0%)patients":[41],"given":[43,48,55,65,81,83,85,91,95,98,101,104],"single":[44,49],"beta-antagonists,33(10.9%)patients":[46],"calcium":[50,60,70,77,127],"blockers,and":[52],"166(54.8%)patients":[53],"beta-antagonists":[57,68,125],"combined":[58],"with":[59,112],"blockers.The":[62],"other":[63],"13(4.3%)were":[64],"neither":[66],"nor":[69],"blockers.In":[72],"199":[73],"who":[75],"received":[76],"blockers,54(27.1%)patients":[79],"verapamil,106(53.3%)were":[82],"diltiazem,39(19.6%)were":[84],"dihydropyridines.\u2461One":[86],"twenty-five(41.3%)patients":[89],"ACE":[92,113,131],"inhibitors/ARB,70(23.1%)patients":[93],"diuretics,17(5.6%)patients":[96],"digoxin,64(21.1%)patients":[99],"nitrates,15(5.0%)patients":[102],"amiodarone.One":[105],"two(33.7%)patients":[108],"inappropriately":[110,135],"treated":[111],"inhibitors/ARB":[114],"diuretics,digoxin,or":[115],"nitrates.Conclusion:The":[116],"most":[117],"popular":[118],"agents":[119],"still":[123],"blockers,but":[129],"sometimes":[130],"inhibitors/ARB,diuretics,digoxin":[132],"or":[133],"nitrates.were":[134],"prescribed.":[136]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}